ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meloxicam Drugs Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-0I18763
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Meloxicam Drugs Market Research Report 2024
BUY CHAPTERS

Global Meloxicam Drugs Market Research Report 2024

Code: QYRE-Auto-0I18763
Report
October 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boehringer Ingelheim
Iroko Pharmaceuticals
Lupin Ltd
Novitium Pharma
Zydus
Nipro
Luye Pharma
Simcere Pharmaceutical
Kelun Pharmaceutical
YaoPharma
Yangtze River Pharmaceutical
Zhejiang Xianju Pharmaceutical
Qilu Pharmaceutical
Jiangsu Jibeier Pharmaceutical

Meloxicam Drugs Market

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with conditions such as osteoarthritis and rheumatoid arthritis. It works by inhibiting the production of certain chemical messengers (prostaglandins) responsible for inflammation, pain, and fever.It is available in various forms, including tablets, capsules, and injections, and is typically prescribed for long-term management of chronic inflammatory conditions.
The global Meloxicam Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Meloxicam Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Meloxicam Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Meloxicam Drugs include Boehringer Ingelheim, Iroko Pharmaceuticals, Lupin, Novitium Pharma, Zydus, Nipro, Luye Pharma, Simcere Pharmaceutical, Kelun Pharmaceutical, YaoPharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meloxicam Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meloxicam Drugs.
The Meloxicam Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Meloxicam Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meloxicam Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Meloxicam Drugs Market Report

Report Metric Details
Report Name Meloxicam Drugs Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Iroko Pharmaceuticals, Lupin, Novitium Pharma, Zydus, Nipro, Luye Pharma, Simcere Pharmaceutical, Kelun Pharmaceutical, YaoPharma, Yangtze River Pharmaceutical, Zhejiang Xianju Pharmaceutical, Qilu Pharmaceutical, Jiangsu Jibeier Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Meloxicam Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Meloxicam Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Meloxicam Drugs Market report?

Ans: The main players in the Meloxicam Drugs Market are Boehringer Ingelheim, Iroko Pharmaceuticals, Lupin, Novitium Pharma, Zydus, Nipro, Luye Pharma, Simcere Pharmaceutical, Kelun Pharmaceutical, YaoPharma, Yangtze River Pharmaceutical, Zhejiang Xianju Pharmaceutical, Qilu Pharmaceutical, Jiangsu Jibeier Pharmaceutical

What are the Application segmentation covered in the Meloxicam Drugs Market report?

Ans: The Applications covered in the Meloxicam Drugs Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Meloxicam Drugs Market report?

Ans: The Types covered in the Meloxicam Drugs Market report are Oral Preparations, Topical Preparations, Injections

Recommended Reports

NSAIDs and Analgesics

Chronic Pain Management

Osteoarthritis Treatments

1 Meloxicam Drugs Market Overview
1.1 Product Definition
1.2 Meloxicam Drugs by Type
1.2.1 Global Meloxicam Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral Preparations
1.2.3 Topical Preparations
1.2.4 Injections
1.3 Meloxicam Drugs by Application
1.3.1 Global Meloxicam Drugs Market Value by Application (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Meloxicam Drugs Market Size Estimates and Forecasts
1.4.1 Global Meloxicam Drugs Revenue 2019-2030
1.4.2 Global Meloxicam Drugs Sales 2019-2030
1.4.3 Global Meloxicam Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Meloxicam Drugs Market Competition by Manufacturers
2.1 Global Meloxicam Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Meloxicam Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Meloxicam Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Meloxicam Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meloxicam Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meloxicam Drugs, Product Type & Application
2.7 Global Key Manufacturers of Meloxicam Drugs, Date of Enter into This Industry
2.8 Global Meloxicam Drugs Market Competitive Situation and Trends
2.8.1 Global Meloxicam Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Meloxicam Drugs Players Market Share by Revenue
2.8.3 Global Meloxicam Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meloxicam Drugs Market Scenario by Region
3.1 Global Meloxicam Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Meloxicam Drugs Sales by Region: 2019-2030
3.2.1 Global Meloxicam Drugs Sales by Region: 2019-2024
3.2.2 Global Meloxicam Drugs Sales by Region: 2025-2030
3.3 Global Meloxicam Drugs Revenue by Region: 2019-2030
3.3.1 Global Meloxicam Drugs Revenue by Region: 2019-2024
3.3.2 Global Meloxicam Drugs Revenue by Region: 2025-2030
3.4 North America Meloxicam Drugs Market Facts & Figures by Country
3.4.1 North America Meloxicam Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Meloxicam Drugs Sales by Country (2019-2030)
3.4.3 North America Meloxicam Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Meloxicam Drugs Market Facts & Figures by Country
3.5.1 Europe Meloxicam Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Meloxicam Drugs Sales by Country (2019-2030)
3.5.3 Europe Meloxicam Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meloxicam Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Meloxicam Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Meloxicam Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Meloxicam Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Meloxicam Drugs Market Facts & Figures by Country
3.7.1 Latin America Meloxicam Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Meloxicam Drugs Sales by Country (2019-2030)
3.7.3 Latin America Meloxicam Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Meloxicam Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Meloxicam Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Meloxicam Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Meloxicam Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meloxicam Drugs Sales by Type (2019-2030)
4.1.1 Global Meloxicam Drugs Sales by Type (2019-2024)
4.1.2 Global Meloxicam Drugs Sales by Type (2025-2030)
4.1.3 Global Meloxicam Drugs Sales Market Share by Type (2019-2030)
4.2 Global Meloxicam Drugs Revenue by Type (2019-2030)
4.2.1 Global Meloxicam Drugs Revenue by Type (2019-2024)
4.2.2 Global Meloxicam Drugs Revenue by Type (2025-2030)
4.2.3 Global Meloxicam Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Meloxicam Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Meloxicam Drugs Sales by Application (2019-2030)
5.1.1 Global Meloxicam Drugs Sales by Application (2019-2024)
5.1.2 Global Meloxicam Drugs Sales by Application (2025-2030)
5.1.3 Global Meloxicam Drugs Sales Market Share by Application (2019-2030)
5.2 Global Meloxicam Drugs Revenue by Application (2019-2030)
5.2.1 Global Meloxicam Drugs Revenue by Application (2019-2024)
5.2.2 Global Meloxicam Drugs Revenue by Application (2025-2030)
5.2.3 Global Meloxicam Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Meloxicam Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Meloxicam Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim Meloxicam Drugs Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Iroko Pharmaceuticals
6.2.1 Iroko Pharmaceuticals Company Information
6.2.2 Iroko Pharmaceuticals Description and Business Overview
6.2.3 Iroko Pharmaceuticals Meloxicam Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Iroko Pharmaceuticals Meloxicam Drugs Product Portfolio
6.2.5 Iroko Pharmaceuticals Recent Developments/Updates
6.3 Lupin
6.3.1 Lupin Company Information
6.3.2 Lupin Description and Business Overview
6.3.3 Lupin Meloxicam Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lupin Meloxicam Drugs Product Portfolio
6.3.5 Lupin Recent Developments/Updates
6.4 Novitium Pharma
6.4.1 Novitium Pharma Company Information
6.4.2 Novitium Pharma Description and Business Overview
6.4.3 Novitium Pharma Meloxicam Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novitium Pharma Meloxicam Drugs Product Portfolio
6.4.5 Novitium Pharma Recent Developments/Updates
6.5 Zydus
6.5.1 Zydus Company Information
6.5.2 Zydus Description and Business Overview
6.5.3 Zydus Meloxicam Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zydus Meloxicam Drugs Product Portfolio
6.5.5 Zydus Recent Developments/Updates
6.6 Nipro
6.6.1 Nipro Company Information
6.6.2 Nipro Description and Business Overview
6.6.3 Nipro Meloxicam Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nipro Meloxicam Drugs Product Portfolio
6.6.5 Nipro Recent Developments/Updates
6.7 Luye Pharma
6.7.1 Luye Pharma Company Information
6.7.2 Luye Pharma Description and Business Overview
6.7.3 Luye Pharma Meloxicam Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Luye Pharma Meloxicam Drugs Product Portfolio
6.7.5 Luye Pharma Recent Developments/Updates
6.8 Simcere Pharmaceutical
6.8.1 Simcere Pharmaceutical Company Information
6.8.2 Simcere Pharmaceutical Description and Business Overview
6.8.3 Simcere Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Simcere Pharmaceutical Meloxicam Drugs Product Portfolio
6.8.5 Simcere Pharmaceutical Recent Developments/Updates
6.9 Kelun Pharmaceutical
6.9.1 Kelun Pharmaceutical Company Information
6.9.2 Kelun Pharmaceutical Description and Business Overview
6.9.3 Kelun Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Kelun Pharmaceutical Meloxicam Drugs Product Portfolio
6.9.5 Kelun Pharmaceutical Recent Developments/Updates
6.10 YaoPharma
6.10.1 YaoPharma Company Information
6.10.2 YaoPharma Description and Business Overview
6.10.3 YaoPharma Meloxicam Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 YaoPharma Meloxicam Drugs Product Portfolio
6.10.5 YaoPharma Recent Developments/Updates
6.11 Yangtze River Pharmaceutical
6.11.1 Yangtze River Pharmaceutical Company Information
6.11.2 Yangtze River Pharmaceutical Description and Business Overview
6.11.3 Yangtze River Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Yangtze River Pharmaceutical Meloxicam Drugs Product Portfolio
6.11.5 Yangtze River Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Xianju Pharmaceutical
6.12.1 Zhejiang Xianju Pharmaceutical Company Information
6.12.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.12.3 Zhejiang Xianju Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhejiang Xianju Pharmaceutical Meloxicam Drugs Product Portfolio
6.12.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.13 Qilu Pharmaceutical
6.13.1 Qilu Pharmaceutical Company Information
6.13.2 Qilu Pharmaceutical Description and Business Overview
6.13.3 Qilu Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Qilu Pharmaceutical Meloxicam Drugs Product Portfolio
6.13.5 Qilu Pharmaceutical Recent Developments/Updates
6.14 Jiangsu Jibeier Pharmaceutical
6.14.1 Jiangsu Jibeier Pharmaceutical Company Information
6.14.2 Jiangsu Jibeier Pharmaceutical Description and Business Overview
6.14.3 Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Product Portfolio
6.14.5 Jiangsu Jibeier Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meloxicam Drugs Industry Chain Analysis
7.2 Meloxicam Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meloxicam Drugs Production Mode & Process
7.4 Meloxicam Drugs Sales and Marketing
7.4.1 Meloxicam Drugs Sales Channels
7.4.2 Meloxicam Drugs Distributors
7.5 Meloxicam Drugs Customers
8 Meloxicam Drugs Market Dynamics
8.1 Meloxicam Drugs Industry Trends
8.2 Meloxicam Drugs Market Drivers
8.3 Meloxicam Drugs Market Challenges
8.4 Meloxicam Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Boehringer Ingelheim
Iroko Pharmaceuticals
Lupin Ltd
Novitium Pharma
Zydus
Nipro
Luye Pharma
Simcere Pharmaceutical
Kelun Pharmaceutical
YaoPharma
Yangtze River Pharmaceutical
Zhejiang Xianju Pharmaceutical
Qilu Pharmaceutical
Jiangsu Jibeier Pharmaceutical
List of Tables
 Table 1. Global Meloxicam Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Meloxicam Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Meloxicam Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Meloxicam Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Meloxicam Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Meloxicam Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Meloxicam Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Meloxicam Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Meloxicam Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Meloxicam Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Meloxicam Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Meloxicam Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Meloxicam Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meloxicam Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Meloxicam Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Meloxicam Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global Meloxicam Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global Meloxicam Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global Meloxicam Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global Meloxicam Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Meloxicam Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global Meloxicam Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Meloxicam Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America Meloxicam Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Meloxicam Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America Meloxicam Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America Meloxicam Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Meloxicam Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Meloxicam Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Meloxicam Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Meloxicam Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Meloxicam Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Meloxicam Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Meloxicam Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Meloxicam Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Meloxicam Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Meloxicam Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Meloxicam Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Meloxicam Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Meloxicam Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Meloxicam Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Meloxicam Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Meloxicam Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Meloxicam Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Meloxicam Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Meloxicam Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Meloxicam Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Meloxicam Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Meloxicam Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global Meloxicam Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global Meloxicam Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global Meloxicam Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global Meloxicam Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Meloxicam Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Meloxicam Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global Meloxicam Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global Meloxicam Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Meloxicam Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Meloxicam Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global Meloxicam Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global Meloxicam Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global Meloxicam Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global Meloxicam Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Meloxicam Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Meloxicam Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global Meloxicam Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global Meloxicam Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Meloxicam Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Boehringer Ingelheim Company Information
 Table 71. Boehringer Ingelheim Description and Business Overview
 Table 72. Boehringer Ingelheim Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Boehringer Ingelheim Meloxicam Drugs Product
 Table 74. Boehringer Ingelheim Recent Developments/Updates
 Table 75. Iroko Pharmaceuticals Company Information
 Table 76. Iroko Pharmaceuticals Description and Business Overview
 Table 77. Iroko Pharmaceuticals Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Iroko Pharmaceuticals Meloxicam Drugs Product
 Table 79. Iroko Pharmaceuticals Recent Developments/Updates
 Table 80. Lupin Company Information
 Table 81. Lupin Description and Business Overview
 Table 82. Lupin Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Lupin Meloxicam Drugs Product
 Table 84. Lupin Recent Developments/Updates
 Table 85. Novitium Pharma Company Information
 Table 86. Novitium Pharma Description and Business Overview
 Table 87. Novitium Pharma Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Novitium Pharma Meloxicam Drugs Product
 Table 89. Novitium Pharma Recent Developments/Updates
 Table 90. Zydus Company Information
 Table 91. Zydus Description and Business Overview
 Table 92. Zydus Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Zydus Meloxicam Drugs Product
 Table 94. Zydus Recent Developments/Updates
 Table 95. Nipro Company Information
 Table 96. Nipro Description and Business Overview
 Table 97. Nipro Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Nipro Meloxicam Drugs Product
 Table 99. Nipro Recent Developments/Updates
 Table 100. Luye Pharma Company Information
 Table 101. Luye Pharma Description and Business Overview
 Table 102. Luye Pharma Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Luye Pharma Meloxicam Drugs Product
 Table 104. Luye Pharma Recent Developments/Updates
 Table 105. Simcere Pharmaceutical Company Information
 Table 106. Simcere Pharmaceutical Description and Business Overview
 Table 107. Simcere Pharmaceutical Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Simcere Pharmaceutical Meloxicam Drugs Product
 Table 109. Simcere Pharmaceutical Recent Developments/Updates
 Table 110. Kelun Pharmaceutical Company Information
 Table 111. Kelun Pharmaceutical Description and Business Overview
 Table 112. Kelun Pharmaceutical Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Kelun Pharmaceutical Meloxicam Drugs Product
 Table 114. Kelun Pharmaceutical Recent Developments/Updates
 Table 115. YaoPharma Company Information
 Table 116. YaoPharma Description and Business Overview
 Table 117. YaoPharma Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. YaoPharma Meloxicam Drugs Product
 Table 119. YaoPharma Recent Developments/Updates
 Table 120. Yangtze River Pharmaceutical Company Information
 Table 121. Yangtze River Pharmaceutical Description and Business Overview
 Table 122. Yangtze River Pharmaceutical Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Yangtze River Pharmaceutical Meloxicam Drugs Product
 Table 124. Yangtze River Pharmaceutical Recent Developments/Updates
 Table 125. Zhejiang Xianju Pharmaceutical Company Information
 Table 126. Zhejiang Xianju Pharmaceutical Description and Business Overview
 Table 127. Zhejiang Xianju Pharmaceutical Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Zhejiang Xianju Pharmaceutical Meloxicam Drugs Product
 Table 129. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
 Table 130. Qilu Pharmaceutical Company Information
 Table 131. Qilu Pharmaceutical Description and Business Overview
 Table 132. Qilu Pharmaceutical Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Qilu Pharmaceutical Meloxicam Drugs Product
 Table 134. Qilu Pharmaceutical Recent Developments/Updates
 Table 135. Jiangsu Jibeier Pharmaceutical Company Information
 Table 136. Jiangsu Jibeier Pharmaceutical Description and Business Overview
 Table 137. Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Product
 Table 139. Jiangsu Jibeier Pharmaceutical Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Meloxicam Drugs Distributors List
 Table 143. Meloxicam Drugs Customers List
 Table 144. Meloxicam Drugs Market Trends
 Table 145. Meloxicam Drugs Market Drivers
 Table 146. Meloxicam Drugs Market Challenges
 Table 147. Meloxicam Drugs Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Meloxicam Drugs
 Figure 2. Global Meloxicam Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Meloxicam Drugs Market Share by Type: 2023 & 2030
 Figure 4. Oral Preparations Product Picture
 Figure 5. Topical Preparations Product Picture
 Figure 6. Injections Product Picture
 Figure 7. Global Meloxicam Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Meloxicam Drugs Market Share by Application: 2023 & 2030
 Figure 9. Hospital Pharmacy
 Figure 10. Retail Pharmacy
 Figure 11. Online Pharmacy
 Figure 12. Global Meloxicam Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Meloxicam Drugs Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Meloxicam Drugs Sales (2019-2030) & (K Units)
 Figure 15. Global Meloxicam Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 16. Meloxicam Drugs Report Years Considered
 Figure 17. Meloxicam Drugs Sales Share by Manufacturers in 2023
 Figure 18. Global Meloxicam Drugs Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Meloxicam Drugs Players: Market Share by Revenue in Meloxicam Drugs in 2023
 Figure 20. Meloxicam Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Meloxicam Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Meloxicam Drugs Sales Market Share by Country (2019-2030)
 Figure 23. North America Meloxicam Drugs Revenue Market Share by Country (2019-2030)
 Figure 24. United States Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Meloxicam Drugs Sales Market Share by Country (2019-2030)
 Figure 27. Europe Meloxicam Drugs Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Meloxicam Drugs Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Meloxicam Drugs Revenue Market Share by Region (2019-2030)
 Figure 35. China Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Meloxicam Drugs Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Meloxicam Drugs Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Meloxicam Drugs Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Meloxicam Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Meloxicam Drugs by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Meloxicam Drugs by Type (2019-2030)
 Figure 54. Global Meloxicam Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Meloxicam Drugs by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Meloxicam Drugs by Application (2019-2030)
 Figure 57. Global Meloxicam Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 58. Meloxicam Drugs Value Chain
 Figure 59. Meloxicam Drugs Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Meloxicam Market Research Report 2024
Meloxicam Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tenoxicam Market Research Report 2024
Global Piroxicam Market Research Report 2024
Global Meloxicam Capsules Market Research Report 2024
Global Meloxicam Tablets Market Research Report 2024
Global Celecoxib Capsule Market Insights Forecast to 2030
Global Celecoxib Market Insights Forecast to 2030
Global Lornoxicam Tablets Market Research Report 2024
Global Rofecoxib Market Insights Forecast to 2030
Global Nonsteroidal Anti Inflammatory Drugs NSAIDs Market Research Report 2024
Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030
Global Piroxicam Patch Market Research Report 2024
Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025
Global Pets NSAIDs Market Research Report 2025
Global Oral Meloxicam Market Research Report 2024
Cox 2 Inhibitors Market
Global Loxoprofen Market Research Report 2024
Global Nimesulide Market Research Report 2024
Global Anti inflammatory Agents Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions